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A B S T R A C T
Purpose: Aggression in people with epilepsy (PWE) is not well understood. We investigated interictal
aggression in PWE and clariﬁed predictors and the interrelationships among them.
Method: This was a case–control study. Eligible subjects who consecutively visited the epilepsy clinic
completed several questionnaires including the Aggression Questionnaire (AQ), the Revised Stigma Scale
(RSS), the Korean version of the Neurological Disorders Depression Inventory for Epilepsy (K-NDDI-E),
and the Generalized Anxiety Disorder-7 (GAD-7).
Results: PWEs had higher overall AQ scores and anger and hostility subscale scores than controls.
Patients with uncontrolled epilepsy also had higher physical and verbal aggression subscale scores than
controls. Univariate analyses revealed associations between the overall AQ score and job, household
income, marriage, antiepileptic drug (AED) load, seizure control, co-administration of psychiatric drugs,
the RSS score, the K-NDDI-E score, and the GAD-7 score. Multivariate analyses indicated that the
strongest predictor for the overall AQ score was the RSS score (b = 0.346, p < 0.001), followed by the
GAD-7 score (b = 0.244, p = 0.003), and the K-NDDI-E score (b = 0.172, p = 0.047). The RSS score exerted a
direct effect on the overall AQ score under the inﬂuences of the GAD-7 score and the K-NDDI-E score. The
GAD-7 score also exerted a direct effect on the overall AQ score, but the K-NDDI-E score only had an
indirect effect on the overall AQ score through the RSS score.
Conclusion: The degree of interictal aggression is higher in PWE than controls. Perceived stigma is a
critical factor for aggression under the inﬂuence of depression and anxiety.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
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Aggression is overt, often harmful, social interaction which is
intended to inﬂict damage or other unpleasantness upon anotherAbbreviations: TLE, temporal lobe epilepsy; PWE, people with epilepsy; AED,
antiepileptic drug; LEV, levetiracetam; GE, generalized epilepsy; PDD, prescribed
daily dose; DDD, deﬁned daily dose; WCE, well-controlled epilepsy; PCE, poorly-
controlled epilepsy; UCE, uncontrolled epilepsy; AQ, Aggression Questionnaire;
RSS, Revised Stigma Scale; K-NDDI-E, Korean version of the Neurological Disorders
Depression Inventory for Epilepsy; GAD-7, Generalized Anxiety Disorder-7; MDD,
major depressive disorder; GFI, Goodness of Fit Index; RMR, Root Mean-square
Residual; VIF, variance inﬂation factor; SCID, Structured Clinical Interview for DSM-
IV axis I disorders.
* Corresponding author at: Department of Neurology, School of Medicine,
Kyungpook National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 700-842,
Republic of Korea. Tel.: +82 53 420 5769; fax: +82 53 422 4265.
E-mail address: sppark@mail.knu.ac.kr (S.-P. Park).
1 These authors contributed equally to the manuscript as ﬁrst authors in this
study.
http://dx.doi.org/10.1016/j.seizure.2015.01.011
1059-1311/ 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reindividual [1]. Aggression takes a variety of forms including
aggression-related feelings such as anger or hostility, and
aggression-related behaviors such as physical or verbal aggression
[2]. Overall, data from human and animal studies suggest that
subcortical brain regions, particularly the limbic system and more
speciﬁcally the amygdala, are associated with aggression [3].
Epilepsy is a model for brain–behavior relationships because
seizures affect behavior, and behavior affects seizures [4]. Patients
with temporal lobe epilepsy (TLE) frequently have damage to the
limbic area, which might lead one to predict that they would
show more aggression than patients with other forms of epilepsy.
It has been reported that interictal anger is more frequent in
patients with TLE than in healthy controls [5]. Blumer described an
interictal dysphoric disorder in patients with TLE, which is
characterized by marked irritability and troublesome loss of
control [6].
Although it has been reported that patients with TLE are more
aggressive than healthy controls during the interictal period, there
is no clear evidence that the overall people with epilepsy (PWE)served.
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period. Numerous potential predictors of aggression have been
suggested, e.g. seizure-related factors, medical factors and
psychosocial factors [4], but there has been no investigation into
which of these potential predictors are more critical. The aims of
our study were to investigate interictal aggression in PWE and to
clarify predictors for aggression and the relationships among them.
2. Methods
2.1. Subjects
We included consecutive participants from PWE who attended
our epilepsy clinic between October 1, 2013 and January 31,
2014 and were taking antiepileptic drugs (AEDs). Patients were
over 19 years old, had a current diagnosis of epilepsy, had been
taking one or more AEDs for at least 1 year and were capable of
providing informed consent and understanding the study protocol.
Patients with an intellectual disability or serious medical,
neurological or psychiatric disorders, or problems with alcohol
or drugs that prevented them understanding the questionnaire and
cooperating in study procedures were excluded as were patients
who declined to answer the questionnaires. We also excluded
patients who had an overt seizure in the four days preceding the
start of the study. We recruited age- and gender-matched controls
as a comparison group; most controls were parents, siblings,
offspring or relatives of patients although some were medical
students or hospital employees. Control subjects were free of
epilepsy and had no history of loss of consciousness.
2.2. Study design
This case–control study was approved by the institutional
review board of Kyungpook National University Hospital and all
subjects provided written informed consent before participation.
Epilepsy was diagnosed according to the International League
Against Epilepsy classiﬁcation of seizures and epileptic syndromes
[7,8]. All subjects were interviewed by a trained epileptologist (SP
Park) who collected demographic, socioeconomic, and clinical
information from patients’ medical charts; this information was
entered into a computerized database.
The demographic variables were age, gender, and education.
The socioeconomic variables were employment status (employed
versus unemployed), household income (at least one million
Korean won (KRW) per month [equivalent to US$ 900 per month]
versus less than one million KRW/month), possession of a driving
license (yes versus no) and marital status (married versus divorced,
bereaved, or unmarried). The clinical variables were age at onset of
epilepsy, duration of epilepsy, type of seizure, etiology, epilepsy
syndrome, MRI abnormality, family history of epilepsy, history of
febrile convulsions, duration of AED intake, AED therapy regimen,
AED load, levetiracetam (LEV) intake and degree of seizure control.
Etiology was classiﬁed as idiopathic or cryptogenic/symptomatic.
Four categories of epileptic syndrome were used: TLE; extraTLE
(epilepsy syndromes in which the epileptic attacks originated from
the frontal, parietal, or occipital lobes); generalized epilepsy (GE)
and unknown syndrome. AED regimen was classiﬁed as mono-
therapy or polytherapy according to the number of AEDs the
patient was using. AED load was estimated as the sum of the ratios
of prescribed daily dose (PDD): deﬁned daily dose (DDD; the
assumed average daily maintenance dose of the drug when used
for its main indication [9]) for each AED in the subject’s treatment
regimen [10]. We included LEV intake as a variable because LEV has
been reported to produce anger and aggression [11]. Patients who
took LEV as monotherapy or polytherapy were included in the LEV
intake group. We used three categories for degree of seizurecontrol: well-controlled epilepsy (WCE; seizure freedom in the last
year); poorly-controlled epilepsy (PCE; an intermediate degree of
seizure control that did not meet the criteria for WCE or UCE) and
uncontrolled epilepsy (UCE; drug-refractory epilepsy i.e., failure to
respond to adequate trials of two AEDs, an average of more than
one seizure per month for 18 months and maximum seizure-free
period of less than three months [12]). PWE were assigned to a
seizure control category on the basis of information about seizure
frequency obtained from their medical records. The psychosocial
factors were perceived stigma, depression and anxiety. Eligible
patients completed several self-report questionnaires: the Aggres-
sion Questionnaire (AQ) [13], the Revised Stigma Scale (RSS) [14],
the Korean version of the Neurological Disorders Depression
Inventory for Epilepsy (K-NDDI-E) [15] and the Generalized
Anxiety Disorder-7 (GAD-7) [16].
2.3. Interview and questionnaires
2.3.1. Aggression Questionnaire (AQ)
The AQ was developed by Buss and Perry; it measures
aggressive behavior and consists of 29 items in four subscales:
Physical Aggression (9 items), Verbal Aggression (5 items), Anger
(7 items) and Hostility (8 items) [17]. Responses to all items are
given on a ﬁve-point Likert scale ranging from ‘never’ (1) to
‘always’ (5); subscale scores can be summed to obtain an overall
score. Higher scores indicate greater aggression. A validated
Korean version of the AQ has been produced [13]. During the
validation process, a decision was taken to omit two of the original
items from the anger subscale (‘Some of my friends think I’m a
hothead’ and ‘Sometimes I ﬂy off the handle for no good reason’)
because they related more to verbal aggression and hostility than
anger. After all, 27 items was represented for the evaluation of
aggression. Cronbach’s a coefﬁcient for the Korean version of the
AQ was 0.86.
2.3.2. Revised Stigma Scale (RSS)
Perceived stigma used to be measured using a three-item scale
which was originally developed for the assessment of stigma in
stroke patients [18], but revised and adapted for use with
PWE [19]. Individuals are asked to give a yes/no response to a
question which asks whether they feel that other people are (1)
uncomfortable with them, (2) treat them as inferior and (3) prefer
to avoid them, because of their epilepsy. A ‘yes’ response to an item
scores 1 and an individual’s score is the sum of their positive
responses. Recently, it was shown that this scale is subject to a
ceiling effect which probably reﬂects the use of binary responses
[20]. Thereafter, the RSS was developed and validated [14]. The
RSS uses a four-point Likert scale (0: ‘not at all’; 1: ‘yes, maybe’; 2:
‘yes, probably’; 3: ‘yes, deﬁnitely’), which may have enhanced its
sensitivity to more subtle differences in perception of stigma. The
RSS scores range from 0 to 9; a score of 0 indicates that the person
does not feel stigmatized, scores 1–6 indicate that the person feels
mildly to moderately stigmatized and scores 7–9 indicate that the
person feels very stigmatized. Cronbach’s a coefﬁcient for the RSS
was 0.85.
2.3.3. Korean version of the Neurological Disorders Depression
Inventory for Epilepsy (K-NDDI-E)
The K-NDDI-E is a reliable, validated screening tool for major
depressive disorder (MDD) in Korean PWE [15]. Subjects are asked
to rate six items using a four-point scale (1–4) to indicate how
much they have been bothered by depression-related problems
over the previous two weeks. Total scores range from 6 to 24;
higher scores indicate more intense depression. Cronbach’s a
coefﬁcient was 0.898 and a total score of 12 or more is suggestive
of MDD.
Table 1
Demographic, socioeconomic, clinical, and psychosocial characteristics of eligible
subjects.
Characteristics Mean  SD (range)
or number (%)
p-Value*
PWE Controls
(n = 266) (n = 170)
Age, years 40.2  12.2
(20–70)
40.0  12.1
(20–70)
0.882
Gender, male 167 (62.8) 105 (61.8) 0.840
Education, years 12.9  2.8
(6–20)
14.9  2.5
(6–20)
<0.001
Job, yes 124 (46.6) 120 (70.6) <0.001
Household income,
1 million KRW/month
207 (77.8) 165 (97.1) <0.001
Driving license, yes 168 (63.2) 153 (90.0) <0.001
Married but no divorce or
bereavement
123 (46.2) 107 (62.9) 0.001
Concurrent medical disease 80 (30.1) 20 (11.8) <0.001
Age at onset, years 25.8  13.1
(1–63)
Duration of epilepsy, years 14.4  10.7
(1–57)
Type of seizure, partial 203 (76.3)
Etiology, cryptogenic or
symptomatic
205 (77.1)
Epilepsy syndrome
TLE 120 (45.1)
ExtraTLE 83 (31.2)
GE 57 (21.4)
Unknown 6 (2.3)
MRI, abnormal 121 (45.5)
Family history of epilepsy, yes 20 (7.5)
History of febrile convulsion, yes 62 (23.3)
Duration of AED intake, years 11.3  9.8 (1–54)
AED regimen, monotherapy 131 (49.2)
AED load 1.2  0.9 (0.1–4.6)
Levetiracetam intake 106 (39.8)
Seizure control
WCE 147 (55.3)
PCE 77 (28.9)
UCE 42 (15.8)
Coadministration of
psychiatric drug
36 (13.5)
Revised Stigma Scale 1.6  2.2 (0–9)
Not stigmatized 137 (51.5)
Mildly to moderately
stigmatized
118 (44.4)
Highly stigmatized 11 (4.1)
* Independent t test or Chi-square test was applied.
PWE: people with epilepsy, KRW: Korean Won, TLE: temporal lobe epilepsy,
extraTLE: extratemporal lobe epilepsy, GE: generalized epilepsy, MRI: magnetic
resonance imaging, AED: antiepileptic drug, WCE: well-controlled epilepsy, PCE:
poorly controlled epilepsy, UCE: uncontrolled epilepsy.
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The GAD-7 is a self-report questionnaire used for the rapid
detection of generalized anxiety disorder (GAD) [21]. Subjects are
asked to rate seven items using a four-point scale (0–3) to indicate
how much they have been bothered by anxiety-related problems
over the previous two weeks. Total GAD-7 scores range from 0 to
21; higher scores indicate more intense anxiety. We used a Korean
version of the GAD-7 which can be downloaded from the Patient
Health Questionnaire website (www.phqscreeners.com) [22]. We
have recently validated the GAD-7 in Korean PWE [16]. Cronbach’s
a coefﬁcient was 0.924 and a total score of 7 or more is suggestive
of GAD.
2.4. Statistical analysis
We have presented a set of descriptive statistics: counts,
percentages, means and standard deviations. Comparisons be-
tween groups were made using independent t-test, Chi-square
test, or ANCOVA. Pearson’s correlation coefﬁcient was calculated
for continuous independent variables to determine the relation-
ship between various demographic or clinical variables and overall
AQ score. Variables that were signiﬁcantly correlated with overall
AQ score were then included in a multiple linear regression
analysis with stepwise selection using entry and exit probabilities
of 0.05 and 0.1, respectively. Collinearity statistical analysis was
performed to assess collinearity. One-way ANOVA was used to
assess the relationship between perceived stigma and overall AQ
score.
Findings from the linear regression analyses were used to
construct a structural equation model which was used to assess the
interrelationships between important variables and the overall AQ
score. On the basis of a review of previous studies [4,23–27], we
developed a hypothetical model outlining the path between
selected variables and aggression. The hypothetical path model
was tested against the structural equation model. Model ﬁt was
evaluated using path analysis, a method of estimating the relative
importance of different paths from independent variables to the
dependent variable. We deﬁned acceptable model ﬁt as having a
non-signiﬁcant chi-square (x2) value, Goodness of Fit Index (GFI)
of 0.9, and Root Mean-square Residual (RMR) of 0.05.
All statistical analyses except the structural equation model
were conducted using SPSS (version 19.0, IBM Inc.). LISREL 8.8 for
Windows (Scientiﬁc Software International, USA) was used for
path and structural equation modeling. We used a signiﬁcance
level of p < 0.05 for all statistical tests.
3. Results
A total of 370 patients were initially enrolled in this study; 104
patients were excluded because they refused to complete the
questionnaires (n = 36), were unable to complete the question-
naires owing to intellectual disability (n = 24), had a serious
disease (n = 18), were too old age (n = 16) or had suffered an overt
seizure in the four days before the study (n = 10). The ﬁnal sample
consisted of 266 patients (mean age: 40.2  12.2 years; 62.8%
males) and 170 controls (mean age: 40.0  12.1 years; 61.8% males).
The demographic, socioeconomic, clinical, and psychosocial char-
acteristics of subjects are summarized in Table 1. The PWE group had
a lower mean educational level, were less likely to be employed, had a
lower mean income, were less likely to hold a driving license or be
married and more likely suffer from other medical conditions than
controls. Concurrent medical diseases in PWE were hypertension and
other cardiovascular disorders (n = 23), diabetes and other endocrine
disorders (n = 23), cerebrovascular disease and other neurologic
disorders (n = 22), hepatic and gastrointestinal disorders (n = 8),
orthopedic diseases (n = 5), autoimmune diseases (n = 5) and otherunspeciﬁed diseases (n = 11). Concurrent medical diseases in the
controls were hypertension and other cardiovascular disorders
(n = 10), diabetes and other endocrine disorders (n = 7), cerebrovas-
cular disease and other neurologic disorders (n = 2), and other
diseases (n = 4). Among PWE, 203 patients (76.3%) had partial
seizures and 205 patients (77.1%) had. cryptogenic or symptomatic
etiology. The most common epilepsy syndrome was TLE, followed by
extraTLE, GE, and unknown syndrome. The frequency of monotherapy
was 49.2% and 39.8% of patients took LEV. As to seizure control,
147 patients (55.3%) manifested WCE, whereas 42 patients (15.8%)
represented UCE. Co-administered psychiatric drugs were antide-
pressants (n = 22), anxiolytics (n = 19), and antipsychotics (n = 2).
Mean RSS score was 1.6  2.2 and 137 patients had no stigma (51.5%),
118 patients (44.4%) were mild to moderate stigmatized, and 11
patients (4.1%) were highly stigmatized.
The degree of interictal aggression, depression, and anxiety in
PWE compared with controls were listed in Table 2. Mean scores of
the overall AQ, anger, hostility, the K-NDDI-E, and the GAD-7 were
Table 2
Interictal aggression, depression, and anxiety in people with epilepsy compared with controls.
Mean  SD (range)
PWE WCE PCE UCE Controls
(n = 266) (n = 147) (n = 77) (n = 42) (n = 170)
Overall AQ 54.2  14.5 (27–121)b 51.3  13.4 (27–101) 55.7  13.6 (34–98)b 61.2  17.3 (35–121)b 49.8  10.0 (27–84)
Physical aggression 15.6  5.5 (9–44) 14.6  4.7 (9–34) 15.7  5.1 (9–33) 18.7  7.6 (9–44)b 14.7  4.2 (9–30)
Verbal aggression 11.0  3.6 (5–24) 10.6  3.2 (5–20) 11.2  3.7 (5–21) 11.7  4.3 (5–24)a 10.7  2.8 (5–18)
Anger 12.6  3.7 (5–24)b 11.9  3.7 (5–24) 13.0  3.5 (6–21)b 14.2  3.6 (6–21)b 11.2  3.0 (5–20)
Hostility 15.0  5.8 (8–37)b 14.2  5.7 (8–37) 15.8  5.8 (8–34)b 16.6  5.7 (8–33)b 13.2  3.2 (8–22)
K-NDDI-E 10.2  4.5 (6–24)b 9.3  3.8 (6–24) 10.1  4.4 (6–24)a 13.4  5.7 (6–24)b 8.4  2.6 (6–18)
GAD-7 4.8  5.4 (0–21)b 3.4  4.3 (0–21) 5.3  5.9 (0–21)b 8.6  6.1 (0–21)b 3.0  2.9 (0–12)
Analysis of covariance controlling for education was conducted for the comparisons between epilepsy groups and controls.
a p < 0.05.
b p < 0.01.
PWE: people with epilepsy, WCE: well-controlled epilepsy, PCE: poorly controlled epilepsy, UCE: uncontrolled epilepsy, AQ: Aggression Questionnaire, K-NDDI-E: Korean
version of the Neurological Disorders Depression Inventory for Epilepsy, GAD-7: Generalized Anxiety Disorder-7.
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tendency was observed in patients with PCE or UCE. In patients
with UCE, mean scores of physical and verbal aggressions were also
higher than those of controls.
Variables associated with the overall AQ score by univariate
analyses are summarized in Table 3. The overall AQ score were
higher in patients with no job (p = 0.009), low household income
(p < 0.001), unmarried state, divorce, or bereavement (p = 0.044),
high AED load (p = 0.033), poor seizure control (p < 0.001), co-
administration of psychiatric drugs (p < 0.001), and high scores of
the RSS (p < 0.001), the K-NDDI-E (p < 0.001), and the GAD-7
(p < 0.001).
Predictors of the overall AQ score by multivariate analyses are
listed in Table 4. The strongest predictor was the RSS score
(b = 0.346, p < 0.001), followed by the GAD-7 score (b = 0.244,
p = 0.003), and K-NDDI-E score (b = 0.172, p = 0.047). Stepwise
regression produced a three-variable model that explained 43.9% of
the variance in the overall AQ score. According to the standardizedb,
the contribution of the RSS score to the overall AQ score was
1.42 times greater than that of the GAD-7 score, and 2.01 times
greater than that of the K-NDDI-E score. The variance inﬂation factor
(VIF) was less than 10 for all three variables, which suggested that
they exerted independent effects without redundancy. Although
seizure control was signiﬁcantly correlated with the overall AQ
score, it was not a signiﬁcant predictor for aggression. Mean overall
AQ scores with respect to the degree of perceived stigma were
illustrated in Fig. 1. The highest overall AQ score was manifested in
highly stigmatized PWE, followed by mildly to moderately
stigmatized PWE, and no stigmatized PWE (one-way ANOVA,
F = 56.513, p < 0.001). Post hoc tests with Tukey’s HSD revealed
signiﬁcant differences between groups (p < 0.001).Table 3
Variables correlated with the overall AQ score in people with epilepsy.
Variable p-Value (r)*
Job 0.009 (0.160)
Household income <0.001 (0.237)
Marriage 0.044 (0.124)
AED load 0.033 (0.130)
Seizure control <0.001 (0.247)
Coadministration of psychiatric drugs <0.001 (0.242)
RSS <0.001 (0.588)
K-NDDI-E <0.001 (0.585)
GAD-7 <0.001 (0.579)
* Pearson’s correlation was applied.
AQ: Aggression Questionnaire, AED: antiepileptic drug, RSS: Revised Stigma Scale,
K-NDDI-E: Korean version of the Neurological Disorders Depression Inventory for
Epilepsy, GAD-7: Generalized Anxiety Disorder-7.The complex interrelationships between important variables
and the overall AQ score are illustrated in a structural equation
model shown in Fig. 2. According to predeﬁned criteria, the ﬁnal
model provided an excellent ﬁt to the data (x2 = 3.59, p = 0.31;
GFI = 0.99, and RMR = 0.016). All regression coefﬁcients were
statistically signiﬁcant (p < 0.01). Bidirectional relationship was
noted between the GAD-7 score and the K-NDDI-E score. The RSS
score exerted a direct effect on the overall AQ score under the
inﬂuences of the GAD-7 score and the K-NDDI-E score. The GAD-7
score also exerted a direct effect on the overall AQ score, but the K-
NDDI-E score only had an indirect effect on the overall AQ score
through the RSS score.
4. Discussion
Our study showed that the degree of interictal aggression,
especially interictal anger or hostility, was signiﬁcantly higher in
PWE than controls. Moreover, aggression-related behavior such as
physical or verbal aggression was also higher in patients with UCE.
Several variables were related to aggression, but perceived stigma
was critical after controlling for depression and anxiety. Perceived
stigma provoked aggression under the inﬂuence of depression and
anxiety.
We found that PWE had a higher overall AQ score and higher
anger and hostility subscales scores than controls. Recently, an
Italian multicenter study examined interictal aggression in PWE
who had focal or generalized epilepsy [28]. On the contrary to our
results, it demonstrated that PWE represented a lower overall AQ
score and lower all subscales scores except anger than the general
population. The discrepancy between two studies may be relied on
the characteristics of the control group. We mostly enrolled
patients’ parents, sibling, offspring, or relative as controls. On the
other hand, an Italian study used the general population as
controls. Because a familial tendency is likely to be a factor to
determine behavioral disorders, our control subjects may haveTable 4
Predictors of the overall AQ score in people with epilepsy by stepwise linear
regression analyses.
Variable Standardized
coefﬁcients (b)
p-Value Collinearity
(VIF)
Adjusted
R2
0.439
RSS 0.346 <0.001 1.616
GAD-7 0.244 0.003 3.209
K-NDDI-E 0.172 0.047 3.520
AQ: Aggression Questionnaire, RSS: Revised Stigma Scale, GAD-7: Generalized
Anxiety Disorder-7, K-NDDI-E: Korean version of the Neurological Disorders
Depression Inventory for Epilepsy.
Fig. 1. Interictal aggression with respect to the degree of perceived stigma in people
with epilepsy (PWE). The highest overall AQ score was acquired by highly
stigmatized PWE (n = 11), followed by mildly to moderately stigmatized PWE
(n = 118), and no stigmatized PWE (n = 137) (one-way ANOVA, F = 56.513,
p < 0.001). Post hoc tests with Tukey’s HSD revealed signiﬁcant differences
between groups (*p < 0.001). Error bars represent 95% conﬁdence intervals. The RSS
scores range from 0 to 9, with a score of 0 indicating that the person does not feel
stigmatized, scores of 1–6 indicating that the person feels mildly to moderately
stigmatized, and scores of 7–9 indicating that the person feels highly stigmatized.
AQ: Aggression Questionnaire, RSS: Revised Stigma Scale.
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consider the ethnic or cultural difference as another reason for the
discrepancy. We found the degree of aggression was signiﬁcantly
higher in patients with PCE or UCE than controls, but patients with
WCE were similar with controls as the degree of aggression.
However, an Italian study could not ﬁnd any signiﬁcant relation-
ship between seizure frequency and aggression despite of some
correlated tendency [28]. Because we included the number of AED
trial and seizure-free interval in addition to seizure frequency
when deﬁning seizure control, our results could be different from
those of the Italian study. We manifested that patients with UCE
had physical and verbal aggressions, which were not present in
patients with WCE or PCE. Aggression-related behavior is more
likely to harm another person than aggression-related feelings
such as anger and hostility. Therefore, we recommend clinician
should screen aggressiveness in patients with UCE to prevent them
from eliciting more serious psychosocial problems.Fig. 2. Interrelationships between independent variables and the overall AQ score
by a structural equation model. An arrow indicates a direct relationship from one
variable to another. Numbers denote standardized regression coefﬁcients (beta
weights) for each path. If the sign of the coefﬁcient is negative, when the predictor
variable score increases by 1 standard deviation. The overall AQ score decreases by
the number of standard deviations as indicated by the value of the coefﬁcient. All
regression coefﬁcients are statistically signiﬁcant (p < 0.01). GAD-7: Generalized
Anxiety Disorder-7, RSS: Revised Stigma Scale, K-NDDI-E: Korean version of the
Neurological Disorders Depression Inventory for Epilepsy, AQ: Aggression
Questionnaire.We reported that no job, low household income, unmarried,
divorce or bereavement, high AED load, poor seizure control, co-
administration of psychiatric drugs, high perceived stigma,
depression, and anxiety were associated with aggression. An
Italian study also demonstrated that psychiatric disturbances were
associated with aggression, but job, marital state, and seizure
frequency were not [28]. Instead, it reported that intellectual
functioning, disability, geographic distribution, level of education,
age, and disease duration were associated with aggression. It did
not consider household income, AED load, intake of psychiatric
drugs, and stigma as variables to determine aggression. Since
demographic and socioeconomic factors may differently affect on
aggression with respect to ethnic or cultural difference, we think it
produce different results. Our study could not prove that LEV
intake is associated with aggression [11]. Because it is a cross-
sectional study, a longitudinal study which observes the change of
aggression before and after LEV intake should be needed to prove
it. Besides LEV, barbiturates, benzodiazepines, vigabatrin, zonisa-
mide, lamotrigine, gabapentin, and topiramate have been known
to provoke irritability and aggression in PWE, especially those with
intellectual disabilities [29]. We cannot exclude the impact of
those AEDs on behaviors in PWE. Therefore, further studies to
clarify the association of individual AED with aggression should be
warranted.
The Italian study reported that several factors were associated
with aggression in PWE but did not assess their relative
importance [28]. We found perceived stigma, depression, and
anxiety were the major predictors for aggression in PWE. As we
know, our study ﬁrstly reports psychosocial factors are more
important to provoke aggression than demographic, socioeconom-
ic or clinical factors in PWE. Especially, we demonstrated that the
contribution of the perceived stigma to aggression was higher than
that of depression or anxiety. In a review of the literatures related
to stigma of epilepsy, perceived stigma was highly associated with
incomplete seizure control and poor psychosocial outcomes, such
as depression, anxiety, and social isolation, for PWE [27]. A Korean
hospital-based study reported that the frequency of perceived
stigma in epilepsy was higher in patients with depression or
anxiety than those without depression or anxiety [23]. Although
there was no study to elucidate the relationship between stigma of
epilepsy and aggression, we suggest PWE could express aggres-
siveness, anger, and hostility when they feel that other people are
uncomfortable with them, treat them as inferior, and prefer to
avoid them. There is evidence that depression in PWE is closely
related to their aggression. Anger was a constituent component of
depression among PWE, but not among idiopathic major depres-
sion patients [24]. Our results are consistent with this study as we
found that PWE were more aggressive and had more symptoms of
depression than controls. It seems likely that a common pathology
underlies anxiety and aggression. Amygdala function is known to
play an important role in anxiety [30] and is also associated with
emotional control processes and aggression [3]. This is consistent
with our ﬁnding that PWE were more aggressive and more anxious
than controls. Taken together these ﬁndings suggest there are
complex interrelationships among psychosocial variables when
they contribute to aggression.
Epilepsy is recognized as a stigmatizing condition, although not
all PWE experience stigma. Epilepsy has also been associated with
learned helplessness, depression and anxiety, impaired physical
health status, somatic symptoms and other health problems,
reduced self-esteem and reduced life satisfaction [14,31]. There-
fore, it is required to understand the origins of stigma for PWE and
how to reduce its impact. We proved that perceived stigma exerted
a direct effect on aggression under the inﬂuences of depression
and anxiety through a reﬁned path analysis model. Although
interventions for PWE in a clinical setting are of unproven beneﬁt
J.-G. Seo et al. / Seizure 26 (2015) 26–31 31to overcome stigma, this relationship may give us some hints about
the intervention for reducing stigma. That is, not only increasing
knowledge about epilepsy and doing interventions to improve self-
esteem [27], but also relieving depression and anxiety seem likely
to be helpful for reducing perceived stigma in PWE. Through these
efforts, aggression will be decreased or disappeared after all. To
accomplish the goal, clinicians should screen and treat depression
and anxiety in PWE, especially who have uncontrolled seizures, to
reduce perceived stigma and aggressive behavior.
There are some limitations to this study. First, subjects were
recruited at a tertiary care hospital and predictors of aggression
may differ between this population and the community population
of PWE. Second, our data on anxiety and depression were not based
on a structured interview, such as the Structured Clinical Interview
for DSM-IV Axis I disorders (SCID) [32], which is considered the
gold standard in psychiatric research. The SCID is a lengthy
procedure and cannot be used in busy clinical setting so we
decided to use the K-NDDI-E and the GAD-7 to index symptoms of
depression and anxiety. Third, our study was cross-sectional and
therefore only provides a snapshot of the associations between
aggression and the variables investigated, in a single cohort of
patients. A prospective study would enable investigation of
changes over time, or the effects of speciﬁc interventions.
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